Complementary expertise, a common culture.

The health agenda is among the most high-profile in society, but with it comes both complexity and challenge.

Our extensive and experienced team is heavily invested in the topics and trends which are shaping the industry today. As a result, they can quickly bring their expertise to bear to help you navigate the landscape, overcome any barriers and achieve your objectives.

From locally provided primary and community care through to large scale infrastructure projects, we have an intimate knowledge of the healthcare system. When combined with our experience in supporting a broad range of activity across the life science community in drug discovery, biotech, gene therapy, diagnostics, medical devices, and med tech (including digital health), from start-ups to research institutions and high-profile multinationals, our ability to support and guide the broad health sector client community is market leading.

Key Contacts

Bridgepoint Growth

We advised Bridgepoint Growth I with a capital investment into PharmaReview, a UK provider of compliance and copy review services to the life sciences sector.

Hamberley Care Homes

We are Scottish advisers to Hamberley Care Homes Group, providing a multi-disciplinary service including advice on property, corporate finance, regulatory, banking, construction and employment law.

NHS Lothian

We advised NHS Lothian on a Design and Build Development Agreement for the £3million refurbishment of the Panmure St Ann's school building into a health and care centre for Edinburgh’s homeless population.

Aedifica

We advised Aedifica, a pan European Healthcare REIT, on the Scots law aspects of the acquisition of a substantial UK care home portfolio comprising 92 care homes, of which 10 were located in Scotland.

Work Highlights

Welltower Inc

We advised Welltower Inc, a global investor in healthcare real estate, in the Scottish aspects of a £540 million refinance of HC-One’s existing debt facilities, involving a UK-wide portfolio of HC-One operated care homes, with around 50 in Scotland.

Cello Health

We've worked with this leading and fast growing US and European Strategic Healthcare and Life Sciences advisory group for over a decade, supporting them on various matters relating to property, employment and acquisitions. Most recently we advised on the restructure and alignment of a number of their business to form a new technology centric division.

The Wellcome Trust

We advised the Wellcome Trust, a charity dedicated to medical research and new drug discoveries, on the Scots law aspects of its recommended public takeover of Urban&Civic plc, a regeneration-focused property development company.

US MedTech

We advised a US based MedTech company that has pioneered unique medical devices and therapies in relation to a strategic alliance and consulting agreement with a leading Scottish University.

Hub West Scotland

We are advising Hub West Scotland on a Design and Build Development Agreement for the £50million development for a new North East Health Hub on a site near Parkhead, Glasgow - the largest health centre in Scotland.

Scottish Enterprise

We provide ongoing investment advice to Scottish Enterprise, which includes a variety of investments in the life science and healthcare sector. Recent transactions include their participation in a £2.4m funding round into Clinspec Diagnostics (an early cancer detection tech pioneer) and a £1.7m funding round into Cumulus Oncology, Europe’s first oncology drug discovery accelerator.

Highlands & Islands Enterprise

We are advising Highlands & Islands Enterprise on the procurement and construction of the Life Sciences Innovation Centre, consisting of a teaching and research facility for the University of the Highlands & Islands and commercial space for Highlands & Islands Enterprise.

Related Services

Related News, Insights & Events